FIELD: organic chemistry, biochemistry, medicinal chemistry, pharmacy. SUBSTANCE: invention relates to methods for modulation of function of serine/threonine-protein kinases with 5-azaquinoxaline-base compounds. Methods involve using cells expressing serine/threonine-protein kinase, such as RAF. Except for, invention describes methods for prophylaxis and treatment associated with disturbances in metabolism of serine/threonine-protein kinase in pathological states in body using compound defined in the invention. Invention relates also to 5- azaquinoxaline-base compounds and pharmaceutical compositions comprising these compounds. EFFECT: expanded assortment of agents regulating function of serine/threonine-protein kinase. 40 cl, 4 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SERINE-THREONINE PROTEIN KINASE AND PARP MODULATORS | 2013 |
|
RU2681209C2 |
| NOVEL COMPOUNDS AND USE THEREOF IN THERAPY | 2004 |
|
RU2412190C2 |
| PYRROLOPYRIMIDINES USED AS PROTEIN KINASE INHIBITORS | 2006 |
|
RU2434871C2 |
| PYRAZOLE DERIVATIVES APPLIED AS PROTEIN KINASE INHIBITORS | 2001 |
|
RU2340611C2 |
| BENZIMIDAZOLES USED AS PROTEIN KINASE INHIBITORS | 2006 |
|
RU2415853C2 |
| PYRROLE COMPOUNDS AS INHIBITORS OF ERK PROTEIN KINASES, THEIR SYNTHESIS AND INTERMEDIATE COMPOUNDS | 2005 |
|
RU2376299C2 |
| SELECTIVE PROTEIN KINASE INHIBITORS | 2012 |
|
RU2612972C2 |
| TRIAZOLES USED AS PROTEIN KINASE INHIBITORS | 2005 |
|
RU2393155C2 |
| CERTAIN PROTEIN KINASE INHIBITORS | 2017 |
|
RU2738837C2 |
| COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS | 2006 |
|
RU2383545C2 |
